Knoll G - Search Results

1

Safety and efficacy after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium: results of a 1-year extension study.

Budde K, Knoll G, Curtis J, Kahana L, Pohanka E, Seifu Y, Neumayer HH. Budde K, et al. Among authors: knoll g. Transplant Proc. 2005 Mar;37(2):912-5. doi: 10.1016/j.transproceed.2004.12.048. Transplant Proc. 2005. PMID: 15848573 Clinical Trial.

2

The care of patients undergoing hemodialysis.

Knoll G, Curtis J. Knoll G, et al. N Engl J Med. 1999 Mar 4;340(9):736-7. N Engl J Med. 1999. PMID: 10068335 No abstract available.

3

Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: results of a 1-year study.

Budde K, Curtis J, Knoll G, Chan L, Neumayer HH, Seifu Y, Hall M; ERL B302 Study Group. Budde K, et al. Among authors: knoll g. Am J Transplant. 2004 Feb;4(2):237-43. doi: 10.1046/j.1600-6143.2003.00321.x. Am J Transplant. 2004. PMID: 14974945 Free article. Clinical Trial.

4

Long-term safety and efficacy after conversion of maintenance renal transplant recipients from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPA, myfortic).

Budde K, Knoll G, Curtis J, Chan L, Pohanka E, Gentil M, Seifu Y, Marrast AC, Neumayer HH; ERL B302 Study Group. Budde K, et al. Among authors: knoll g. Clin Nephrol. 2006 Aug;66(2):103-11. Clin Nephrol. 2006. PMID: 16939066 Clinical Trial.

5

Factors associated with progression of interstitial fibrosis in renal transplant patients receiving tacrolimus and mycophenolate mofetil.

Rush DN, Cockfield SM, Nickerson PW, Arlen DJ, Boucher A, Busque S, Girardin CE, Knoll GA, Lachance JG, Landsberg DN, Shapiro RJ, Shoker A, Yilmaz S. Rush DN, et al. Transplantation. 2009 Oct 15;88(7):897-903. doi: 10.1097/TP.0b013e3181b723f4. Transplantation. 2009. PMID: 19935461 Clinical Trial.

6

The impact of renal transplantation on survival in hepatitis C-positive end-stage renal disease patients.

Knoll GA, Tankersley MR, Lee JY, Julian BA, Curtis JJ. Knoll GA, et al. Am J Kidney Dis. 1997 Apr;29(4):608-14. doi: 10.1016/s0272-6386(97)90345-0. Am J Kidney Dis. 1997. PMID: 9100052

7

Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation.

Knoll GA, MacDonald I, Khan A, Van Walraven C. Knoll GA, et al. J Am Soc Nephrol. 2003 Sep;14(9):2381-6. doi: 10.1097/01.asn.0000079616.71891.f5. J Am Soc Nephrol. 2003. PMID: 12937317

8

Sirolimus use and de novo minimal change nephropathy following renal transplantation.

Mainra R, Mulay A, Bell R, Karpinski J, Hoar S, Knoll G, Robertson S, Wang D. Mainra R, et al. Among authors: knoll g. Transplantation. 2005 Dec 27;80(12):1816. doi: 10.1097/01.tp.0000181385.68835.a0. Transplantation. 2005. PMID: 16378080 No abstract available.

9

Conversion from calcineurin inhibitors to sirolimus for chronic renal allograft dysfunction: a systematic review of the evidence.

Mulay AV, Cockfield S, Stryker R, Fergusson D, Knoll GA. Mulay AV, et al. Transplantation. 2006 Nov 15;82(9):1153-62. doi: 10.1097/01.tp.0000237101.58974.43. Transplantation. 2006. PMID: 17102766 Review.

10

Treatment of polyomavirus infection in kidney transplant recipients: a systematic review.

Johnston O, Jaswal D, Gill JS, Doucette S, Fergusson DA, Knoll GA. Johnston O, et al. Transplantation. 2010 May 15;89(9):1057-70. doi: 10.1097/TP.0b013e3181d0e15e. Transplantation. 2010. PMID: 20090569 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

422 results

Search Page

Filters